Norgine Ventures Management Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS UK. Norgine Ventures Management Limited is a limited company registered in England and Wales with company number 08723417. NORGINE and the sail logo are trademarks of the Norgine group of companies.
Norgine Ventures Management Limited is authorised and regulated by the Financial Conduct Authority, registration number 917803.
Investing in smaller and unlisted companies (which may be start-up or early stage businesses) involves risks. These risks include possible loss of capital, illiquidity and dilution. Such companies will often not pay dividends. You should not invest in any such company (or any fund that invests in such companies) unless you understand the risks involved, and have taken advice where necessary. A more detailed statement of risks involved can be found here Risk Warning.
Norgine Ventures and Harbert European Growth Capital complete €6 million financing with SpineGuard
LONDON, UK. 13 September 2018, 07.00 AM GMT. Norgine Ventures announced today that it has provided financing of up to €6 million to SpineGuard SA (“SpineGuard”) in partnership with Harbert European Growth Capital. This investment recognises SpineGuard’s innovative and differentiated portfolio of surgical navigation tools designed to secure the placement of surgical implants and make […]
Norgine Ventures completes €4.5m financing with Nuubo
LONDON, UK. 25 January 2018, 07.00 AM GMT. Norgine Ventures announced today that it has provided financing of up to €4.5 million to Smart Solutions Technologies S.L. (“Nuubo”). This investment recognises the unique and differentiated product offering of Nuubo’s wireless electrocardiogram (ECG) monitoring technology, which fills an underserved gap in the cardiac arrhythmia monitoring market. […]
Norgine Ventures completes €2 million financing with pritidenta
LONDON, UK. 7 November 2017, 08:35 AM GMT. Norgine Ventures announced today that it has provided financing of up to €2 million to pritidenta® GmbH, a company based in Leinfelden-Echterdingen, Germany, which develops and sells innovative materials for use in prosthetic dental products. This investment recognises pritidenta®’s best-in-class aesthetic ceramic materials for the dental CAD/CAM […]
Norgine Ventures completes €10 million financing with caresyntax®
LONDON, UK. 26 September 2017, 1.00 PM BST. Norgine Ventures announced today that it has provided financing of up to €10 million to caresyntax®, a digital healthcare company based out of Berlin and Boston. This investment recognises the unique and differentiated product offering trading under caresyntax® in the rapidly growing market of operating room (“OR”) […]
Norgine Ventures completes €3 million financing with EBS Technologies
London. 19 July 2017, 07.00 AM GMT+1 (or BST). Norgine Ventures announced today that it has provided financing of up to €3 million to EBS Technologies GmbH. This investment recognises the importance of EBS Technologies’ unique, non-invasive therapy, NEXTWAVETM, to address a large unmet need for the treatment of visual field loss due to glaucoma […]
Norgine Ventures completes £4 million financing with Collagen Solutions
London. 14th February 2017, 07.00 AM GMT. Norgine Ventures announced that it has provided financing of up to £4 million to Collagen Solutions plc. This investment recognises the high quality of the collagen products of Collagen Solutions, the opportunity to continue the growth trajectory through commercial expansion and the potential of their pipeline of proprietary […]